Healio3d
Admilparant slows lung function decline in IPF, progressive PF
Receiving admilparant, an oral lysophosphatidic acid receptor 1 antagonist, for 26 weeks lowered percent-predicted FVC ...
PC Magazine3d
FDA Approves 'Loss of Pulse Detection' Feature for Google Pixel Watch 3
Loss of pulse detection uses the watch's existing heart rate sensor and an AI algorithm that processes the data. It should ...
Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript
Operator Ladies and gentlemen, thank you for standing by, and welcome to the COMPASS Pathways Limited fourth quarter 2024 investor call. [Operator instructions] I will now hand today's call over to ...
No to oatmeal, yes to 10-minute walks: How Serena Williams figured out what's best for her body
Serena Williams is a once-in-a-generation athlete. Even after retiring from professional tennis in 2022, she remains deeply in tune with her body. “My body speaks to me in ways that I don’t know if ...
I Tested Microcurrent Devices for 2 Months. This Is the One I Like Best Overall
In the market for a microcurrent device? After two months of testing popular brands like ZIIP, FOREO, NuFACE and Therabody, ...
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
Manufacturing: As a result of FDA approval of RYONCIL in December 2024, the US$23.0 million provision against the value of inventory manufactured and expensed in prior periods was reversed and is now ...
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...